Test Price
2,800 AEDโ Home Collection Available
MYO7A Gene (Deafness, Autosomal Recessive Type 2) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM โ 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed genetic counsellors.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The MYO7A gene test uses Next-Generation Sequencing (NGS) to detect pathogenic variants associated with autosomal recessive deafness type 2 (DFNB2) and Usher syndrome type 1B, delivering results in 3 to 4 weeks. A pre-test genetic counselling session to draw a pedigree chart and document family history of hearing loss is strongly recommended. Sample types accepted include whole blood (EDTA tube), extracted DNA, or a simple blood spot on an FTA card.
| Feature | Our MYO7A NGS Test | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Precision | 99.9% analytical sensitivity; covers all exons + splice sites + CNVs | Limited to pre-defined hot spots; may miss deep intronic or CNVs |
| Method | NGS with bioinformatic analysis for copy number variations | Sanger sequencing (no CNV detection) |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
Physician Insight & Safety Protocols
โAs a Consultant in Medical Genetics specializing in hereditary hearing loss, I confirm that the MYO7A NGS test establishes a definitive molecular diagnosis for DFNB2 and Usher syndrome type 1B. This genetic confirmation is critical for accurate prognosis, determining cochlear implant candidacy, and calculating recurrence risks for family planning.โ
โ Lina Osama Zaki Quteineh, MD | Consultant Medical Genetics | DHA Registration ID: 9294403
โ Medication Advisory
Do not discontinue any prescribed medications (e.g., for vertigo, tinnitus) without consulting your physician. This genetic test does not replace audiological management or treatment.
Safety Exclusion Criteria & Emergency Red Flags
- Children under 6 months without paediatrician referral (Ministry of Health regulation).
- Patients with acute febrile illness โ reschedule collection after recovery.
- Unable to provide informed consent or lack of legal guardian (Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Seek immediate emergency care if: sudden sensorineural hearing loss within 72 hours, acute dizziness with vertigo, or facial nerve palsy.
Patient FAQ & Clinical Guidance
1. What is the MYO7A NGS genetic test used for?
The MYO7A NGS test is used to detect pathogenic variants in the MYO7A gene, which causes autosomal recessive deafness type 2 (DFNB2) and Usher syndrome type 1B. It is the gold standard molecular test for confirming a genetic etiology in patients with congenital or progressive sensorineural hearing loss.
2. What sample types are accepted and how is the test conducted?
We accept whole blood (EDTA tube), extracted DNA, or FTA card blood spots. The test utilizes Next-Generation Sequencing (NGS) technology with bioinformatic analysis for copy number variations (CNVs), ensuring comprehensive coverage of all exons and splice sites. VIP mobile phlebotomy is available daily from 8 AM to 11 PM.
3. How much does the test cost and what is the turnaround time?
The price is 2,800 AED and the turnaround time is 3 to 4 weeks from sample receipt. Direct billing verification is available via WhatsApp at +971 54 548 8731 for most major UAE insurers.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, securely stored, and processed exclusively within the UAE. Results are released only to the ordering physician or the patient upon verified consent, ensuring full alignment with UAE data sovereignty and medical confidentiality regulations.
Clinical & Logistical Metadata
| Test Name | MYO7A Gene (Deafness, Autosomal Recessive Type 2) NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA Tube), Extracted DNA, or FTA Card Blood Spot |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV Detection |
| ICD-10-CM Code | H90.3, H90.5 |
| LOINC Code | 21656-9 |
| DHA Facility License & Laboratory Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | License No: 1143 |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians